Seung Min Shin

Dr. Seung Min Shin is an Assistant Professor in the Department of Anesthesiology at the Medical College of Wisconsin, where he also serves as a member of the Cardiovascular Research Center. With a PhD from the School of Medicine Catholic University in Seoul, South Korea, Dr. Shin has dedicated nearly two decades to pain research at MCW, progressing from postdoctoral fellow to his current faculty position.

• BS, Kunsan National University, South Korea (1993-1997)
• MS, Sungkyunkwan University, South Korea (1997-1999)
• PhD, School of Medicine Catholic University, Seoul (2000-2006)

Dr. Shin's research focuses on the molecular mechanisms of neuropathic pain, with particular expertise in ion channel physiology (Piezo channels, T-type calcium channels) and sensory neuron biology. His work bridges basic science with translational applications, developing novel gene therapy approaches for chronic pain management. Recent publications highlight his investigations into Schwann cell Piezo1 signaling in mechanical hypersensitivity, keratinocyte involvement in chemotherapy-induced neuropathy, and AAV-mediated targeted inhibition of pronociceptive channels.

Analysis of Dr. Shin's 15 most recent publications reveals a strong emphasis on translational pain research, with approximately 60% focusing on novel therapeutic approaches for pain management and 40% examining fundamental mechanisms of pain pathways. His work demonstrates increasing collaboration with vascular biology researchers, particularly in studying cerebral blood flow in neurodegenerative conditions.

• Co-Investigator on multiple NIH-funded grants related to pain mechanisms and therapy development
• Co-holder of patent for sodium channel 1.7 inhibitory peptide for chronic pain treatment
• Active member of American Society for Neuroscience and Korean Society for Molecular and Cellular Biology

Dr. Shin's laboratory maintains active collaborations with the Cardiovascular Research Center and multiple departments at MCW. His research program receives substantial support from NIH-NINDS and private foundations, enabling advanced studies in pain mechanisms and therapeutic development. Current projects focus on sensory neuron-specific gene therapy approaches, Schwann cell-pain interactions, and vascular contributions to cognitive impairment in dementia.